Neurocrine Biosciences Inc (NBIX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 4.77 | 4.29 | 4.03 | 5.90 | 6.19 | |
| DSO | days | 76.48 | 85.14 | 90.50 | 61.85 | 59.00 |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.77
= 76.48
Neurocrine Biosciences Inc's Days Sales Outstanding (DSO) has shown a fluctuating trend over the past five years. In December 2020, the DSO stood at 59.00 days, indicating that it took, on average, 59 days to collect receivables. By December 2021, there was a slight increase to 61.85 days, suggesting a slight delay in collecting receivables.
However, there was a significant increase in DSO by December 2022, reaching 90.50 days, which indicates a longer time taken to collect receivables. This trend continued in December 2023 with a DSO of 85.14 days and a slight improvement by December 2024 at 76.48 days.
The increasing trend in DSO over the years may raise concerns about the company's efficiency in collecting receivables promptly. The company should focus on improving its accounts receivable management to shorten the collection cycle and optimize its cash flow.
Peer comparison
Dec 31, 2024